Two Sigma Investments’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Two Sigma Investments’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-80,000	Closed	-$821K	–	3380
2023 Q2	$821K	Hold	80,000	–	–	﹤0.01%	2062
2023 Q1	$810K	Buy	+80,000	New	+$806K	﹤0.01%	1985

Two Sigma Investments's DALS Position: Q3 2023 in Review

Two Sigma Investments sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 80,000 shares — an estimated $821K sold.

Two Sigma Investments first reported a position in DALS in Q1 2023 and held it in 2 quarters. The position peaked at $821K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Two Sigma Investments reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Two Sigma Investments sold 80,000 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $821K.
Two Sigma Investments first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2023 and held it in 2 quarters.
Two Sigma Investments's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $821K in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.